Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truvada for HIV PrEP in Female Sex Workers in Dakar
NCT02474303Completed
- Sponsor
- Réseau Africain de Recherche sur le SIDA
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Réseau Africain de Recherche sur le SIDA. Primary endpoint: Number/proportion of FSWs who remain in the program at 12 months. Started Jul 2015; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02474303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474303.